Labshake search
Citations for Stemcell Technologies :
1 - 50 of 1635 citations for KGF 2 FGF 10 Human 159a.a since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Developmental Biology 2020Quote: ... 10ng/mL FGF-2 (StemCell Technology), and 5nM Rock inhibitor ...
-
bioRxiv - Immunology 2022Quote: ... recombinant human FGF (25ug/mL; Stem Cell Technologies), and recombinant human EGF (10 ug/mL ...
-
bioRxiv - Cell Biology 2019Quote: ... FGF (10 ng/ul) (BioLegend or StemCell Technologies) for at least 2 hours ...
-
bioRxiv - Cancer Biology 2024Quote: ... 5ng/mL FGF-10 (Stem Cell Technologies, 78037), 37.5 ng/mL Heregulin B-1 (Peprotech ...
-
bioRxiv - Molecular Biology 2021Quote: ... recombinant human basic FGF (20ng/mL, all from Stem Cell Technologies) and 10 ng/ml laminin (Sigma Aldrich) ...
-
bioRxiv - Cancer Biology 2021Quote: ... 20 ng/ml basic-FGF and 2 μg/ml Heparin (StemCell Technologies). L0125 and L0512 GBM tumorspheres were kindly provided by Dr ...
-
bioRxiv - Cancer Biology 2021Quote: ... 20 ng/ml basic-FGF and 2 μg/ml Heparin (StemCell Technologies). S24 Tdtomato/GFP cells were kindly gifted by Dr ...
-
bioRxiv - Microbiology 2022Quote: ... and 100 ng/mL of FGF-10 (all from Stem Cell Technologies), and HAO medium was replaced every 3–4 days.
-
bioRxiv - Cell Biology 2019Quote: ... insulin-like growth factor 2 (IGF2; 20 ng/ml) and fibroblast growth factor (FGF; 10 ng/ml) (BioLegend or StemCell Technologies) along with 5ug/ml polybrene (Sigma ...
-
bioRxiv - Developmental Biology 2022Quote: ... 5 ng/mL FGF-2 (RnD Systems) and 1 µM CHIR99021 (Stem Cell Technologies) with daily medium exchange for 3 days ...
-
bioRxiv - Cell Biology 2021Quote: ... 5 ng/ml FGF-2 (RnD Systems) and 1 μM CHIR99021 (Stem Cell Technologies). Mesoderm induction required daily medium exchanges for 3 days ...
-
bioRxiv - Bioengineering 2021Quote: ... supplemented with 10 ng μL-1 recombinant human IL-2 (StemCell Technologies) and activated with the ImmunoCult Human CD3/CD28 T Cell Activator (StemCell Technologies) ...
-
bioRxiv - Bioengineering 2024Quote: ... supplemented with 10 ng/mL of Human Recombinant IL-2 (STEMCELL TECHNOLOGIES, #78220) and ImmunoCult™ Human CD3/CD28 T Cell Activator (STEMCELL TECHNOLOGIES ...
-
bioRxiv - Cell Biology 2023Quote: ... 5 ng/ml FGF-2 (RnD Systems) and 1 μM CHIR99021 (Stemgent or Stem Cell Technologies). Mesoderm induction required daily medium exchanges for 3 days ...
-
bioRxiv - Microbiology 2023Quote: ... 20 ng/ml FGF (STEMCELL Technologies), 20 ng/ml EGF (STEMCELL Technologies) ...
-
bioRxiv - Cancer Biology 2022Quote: ... rh-FGF (Stem Cell Technologies, Cat #02634) and rh-EGF (Sigma ...
-
bioRxiv - Neuroscience 2022Quote: ... human PDGF-AA (10 ng/ml) and PDGF-BB (10 ng/ml; Shenandoah) and heparin (2 ng/ml; Stem Cell Technologies).
-
bioRxiv - Bioengineering 2021Quote: ... microcapsules carrying HUES-8 cells were immersed in E8 medium for 1 h immediately after encapsulation and then transferred into E6 medium (without FGF-2 and TGF-β1, STEMCELL Technologies) for subsequent cultivation (2000 microcapsules per well) ...
-
bioRxiv - Cell Biology 2021Quote: ... 100 ng/ml fibroblast growth factor (FGF; Stem Cell Technologies), and 5 ug/ml heparin (Millipore Sigma ...
-
bioRxiv - Microbiology 2021Quote: ... 100 ng/ml fibroblast growth factor (FGF; Stem Cell Technologies), and 5 μg/ml heparin (Millipore Sigma) ...
-
bioRxiv - Molecular Biology 2021Quote: ... and human recombinant IL-2 (Stemcell Technologies, Vancouver, Canada). Activated CD4+ T cells were transfected with pVax-CasRx and gRNA plasmids by nucleofection using Lonza 4d nucleofector ...
-
bioRxiv - Cancer Biology 2022Quote: ... human recombinant EGF (2 ng/mL, STEMCELL Technologies, #78006.2), antibiotic-antimycotic (1X ...
-
bioRxiv - Biophysics 2023Quote: ... with the addition of Human Recombinant Interleukin 2 (IL-2, STEMCELL Technologies Inc., USA).
-
bioRxiv - Biophysics 2023Quote: ... with the addition of ImmunoCult Human CD3/CD28/CD2 T Cell Activator and Human Recombinant Interleukin 2 (IL-2, STEMCELL Technologies Inc., USA) as per STEMCELL Technologies Inc ...
-
bioRxiv - Cell Biology 2023Quote: ... with the addition of ImmunoCult Human CD3/CD28/CD2 T Cell Activator and Human Recombinant Interleukin 2 (IL-2, STEMCELL Technologies Inc., USA) as per STEMCELL Technologies Inc ...
-
bioRxiv - Immunology 2022Quote: ... and recombinant human EGF (10 ug/mL; Stem Cell Technologies) in 10% DMSO before long-term cryopreservation (1X107 cells/mL ...
-
bioRxiv - Cancer Biology 2022Quote: ... human bFGF (10 ng/ml, Stem Cell Technologies, cat# 78003) and human EGF (20 ng/ml ...
-
bioRxiv - Biochemistry 2023Quote: ... 10 ng/ml human epidermal growth factor (STEMCELL Technologies, 78006), 20 ng/mL basic fibroblast growth factor (STEMCELL Technologies ...
-
bioRxiv - Bioengineering 2021Quote: ... additionally supplemented with cytokines (Human Recombinant IL-2; Stemcell Technologies - #78036). To stimulate the cells ...
-
bioRxiv - Cell Biology 2023Quote: ... with the addition of 1 μg/L of human interleukin 2 (IL-2, STEMCELL Technologies Inc., USA).
-
bioRxiv - Developmental Biology 2023Quote: ... 10 μg human recombinant bFGF and 10 μg 0.2% heparin solution (all from STEMCELL Technologies, Canada).
-
bioRxiv - Cancer Biology 2023Quote: ... Isolated T cells were seeded at a density of 1 x 106 cells/mL in RPMI medium supplemented with 10 ng/mL human recombinant interleukin 2 (IL2, Stemcell Technologies, Cat. No. 78145.2), 1µg/ml anti-human CD3 antibody (BioLegend ...
-
bioRxiv - Developmental Biology 2023Quote: ... supplemented with 10 ng/ml human FGF2 (Stem Cell Technologies 78003). Individual iPSC colonies were mechanically picked ...
-
bioRxiv - Cancer Biology 2023Quote: ... supplemented with 10% NeuroCult™ Proliferation Supplement (Human) (STEMCELL Technologies, 05753), heparin solution (final concentration ...
-
bioRxiv - Neuroscience 2024Quote: ... with 10% human platelet-derived lysate (Stem Cell Technologies, Cat#06960) and 1% Penicillin-Streptomycin solution (Pen-Strep ...
-
bioRxiv - Bioengineering 2023Quote: ... with the addition of Human Recombinant Interleukin 2 (STEMCELL Technologies, Cat# 78036.3). To prepare 3 mg/ml collagen-I gel ...
-
bioRxiv - Bioengineering 2023Quote: ... and 10 μMY27632 (Stemcell Technologies, 129830-38-2)) on day 0 ...
-
bioRxiv - Bioengineering 2021Quote: ... 10 ng/mL human recombinant Leukemia Inhibitory Factor (LIF, STEMCELL Technologies, 78055.1), and 10 ng/mL GDNF ...
-
bioRxiv - Cancer Biology 2022Quote: ... 10 ng/ml human recombinant basic fibroblast growth factor (STEMCELL Technologies, 78003.1), and 0.679 U/ml heparin (Sigma ...
-
bioRxiv - Bioengineering 2021Quote: ... and 100ng/mL human recombinant Fibroblast Growth Factor 2 (FGF2, STEMCELL Technologies, 78003.1) in RPMI 1640 for 2 days ...
-
bioRxiv - Bioengineering 2021Quote: ... and 100ng/mL human recombinant Fibroblast Growth Factor 2 (FGF2, STEMCELL Technologies, 78003.1) for 2 days ...
-
bioRxiv - Bioengineering 2021Quote: ... 1 ng/mL human recombinant Fibroblast Growth Factor 2 (FGF2, STEMCELL Technologies, 78003.1), 20 ng/mL animal component-free human recombinant Glial Cell Derived Neurotrophic Factor (GDNF ...
-
bioRxiv - Synthetic Biology 2023Quote: ... supplemented with Human Recombinant IL-2 (12.5 ng/mL) (Stemcell Technologies, Cat.#78036), with initial seeding at 1×106 alive cells/mL ...
-
bioRxiv - Synthetic Biology 2023Quote: ... supplemented with Human Recombinant IL-2 (12.5 ng/mL) (Stemcell Technologies, Cat.#78036), IL-7 (5 ng/mL ...
-
bioRxiv - Bioengineering 2021Quote: ... 50 ng/mL recombinant human FMS-like tyrosine kinase 3 ligand (Flt-3) and 10 ng/mL recombinant human thrombopoietin (TPO; StemCell Technologies). On the following day ...
-
bioRxiv - Neuroscience 2023Quote: ... 50 ng/mL recombinant human FMS-like tyrosine kinase 3 ligand (Flt-3) and 10 ng/mL recombinant human thrombopoietin (TPO; StemCell Technologies). After sublethal conditioning of 9-12 weeks old Gaa−/− mice with 7.5 Gy gamma-irradiation (1.6 Gy/min ...
-
bioRxiv - Immunology 2020Quote: ... + 10 ng/ml IL-15 and 10 IU of IL-2 (Stemcell Technologies, Canada). The culture media was replenished every three days with fresh media containing 10 IU of IL-2 and 10 ng/ml IL-15 ...
-
bioRxiv - Immunology 2022Quote: ... + 10 ng/ml IL-15 and 10 IU of IL-2 (Stemcell Technologies, Canada). The culture media was replenished every three days with fresh media containing 10 IU of IL-2 and 10 ng/ml IL-15 ...
-
bioRxiv - Bioengineering 2021Quote: ... and 10 ng/mL human recombinant Epidermal Growth Factor (EGF, STEMCELL Technologies, 78006.1), and passaged using TrypLE™ Express Enzyme.
-
bioRxiv - Bioengineering 2021Quote: ... and 10 ng/mL human recombinant Epidermal Growth Factor (EGF, STEMCELL Technologies, 78006.1), and passaged using TrypLE™ Express Enzyme.